Dr. Farrukh Awan on Clinical Activity of Entospletinib in Patients with CLL
December 7th 2015Farrukh T. Awan, MBBS, discusses a phase II trial examining the clinical activity of entospletinib in patients with chronic lymphocytic leukemia who were previously treated with a B-cell receptor pathway signaling inhibitor.